CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED HOLDINGS CO LIMITED 中國中藥控股有限� 司 De rporated in Hong Kong with li tice of Publication of Annual Report 2024 (the “Current Corporate Communications”) The English and Chinese versions of the Current Corporate Communications of the Company are available on the website of the Company at www ch
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED If you want to receive future Corporate Communications in printed form, please complete and return the enclosed reply form to the Share Registrar or send an email to publicrelation@china-tcm com cn specifying your name, address and request to receive future Corporate Communications in printed form
China Traditional Chinese Medicine Holdings Co. Limited 2023 Annual Report On 15 December 2023, the National Development and Reform Commission and the Ministry of Commerce jointly issued the “Opinions on Supporting the Relaxation of Special Measures on Market Access in the Hengqin Guangdong-Macao Deep Cooperation Zone” (《關於支持橫琴粵澳深度合作區放寬市場准入特別措施的意見》), which points out the relaxation of market access for TCM, encourages Macao medical institutions to develop and produce TCM preparations in Guangdong and Macao medical institutions’ TCM preparation centers, allows Guangdong and Macao medical institutions’ TCM preparation centers to undertake the entrusted preparation of TCM preparations from medical institutions outside Guangdong Province, and supports the transformation of Chinese herb preparations developed by the TCM preparation centers of medical institutions in Guangdong and Macao into innovative TCM, and if complies with relevant regulations, Phase I and II clinical trials may not be conducted
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED margins Affected by multiple factors, the Group’s performance in 2024 declined The revenue for the year ended 31 December 2024 was RMB16 51 billion, representing a decrease of 8 9% compared with the same period of 2023; net profit was RMB0